| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.6M | — |
| R&D Expense | $121.6M | +9.2% |
| SG&A Expense | $35.2M | +9.8% |
| Operating Income | -$81.1M | +43.4% |
| Pre-tax Income | -$70.1M | +48.1% |
| Income Tax | $2.6M | +660.4% |
| Net Income | -$72.7M | +46.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $224.3M | +75.1% |
| Current Assets | $377.4M | +59.8% |
| Total Assets | $438.7M | +44.4% |
| Current Liabilities | $156.9M | +236.9% |
| Total Liabilities | $215.8M | +73.3% |
| Stockholders' Equity | $222.9M | +24.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $42.0M | +195.9% |
| Capital Expenditures | $4.0M | -79.1% |
| Investing Cash Flow | -$44.5M | -150.1% |
| Financing Cash Flow | $98.9M | +259.7% |
| Free Cash Flow | $38.0M | +160.5% |